<circle stroke="#1e77f9" class="srdi68r9" cx="25" cy="25" r="20" fill="none" stroke-width="5">

Drugmakers concerned about legal risk with FDA review program, Reuters reports

PremiumThe Fly

1d ago

Roche: Clinical Momentum Improves Outlook but Valuation Keeps Risk/Reward Balanced at Hold

PremiumRatings

1d ago

Roche upgraded to Neutral from Sell at Goldman Sachs

PremiumThe Fly

2d ago

Roche upgraded to Neutral at Goldman on improved growth potential

PremiumThe Fly

2d ago

PremiumThe FlyWhite House releases details on Trump ‘Great Healthcare Plan’

2d ago

Street sees buying opportunity as Disc Medicine slips on FDA review delay

The Fly

Street sees buying opportunity as Disc Medicine slips on FDA review delay

2d ago

LLY

SNY

Stifel sees weakness in Disc Medicine shares as buying opportunity

The Fly

Stifel sees weakness in Disc Medicine shares as buying opportunity

2d ago

Trump Trade: Trump administration moves to end pharma trade probe

IRON

PremiumThe Fly

3d ago

AMD

Trump administration moves to end U.S. pharma trade probe, Endpoints News says

PremiumThe Fly

4d ago

Roche upgraded to Overweight at Barclays on valuation, clinical catalysts

PremiumThe Fly

11d ago

Roche upgraded to Overweight from Equal Weight at Barclays

PremiumThe Fly

11d ago

PremiumThe FlyRoche upgraded to Overweight from Equal Weight at Barclays

11d ago

Royalty Pharma acquires reaming royalty interest in Evrysdi for $240M upfront

The Fly

Royalty Pharma acquires reaming royalty interest in Evrysdi for $240M upfront

19d ago

RPRX

Trump Trade: Trump strikes deals with nine drugmakers to cut prices

The Fly

Trump Trade: Trump strikes deals with nine drugmakers to cut prices

26d ago

Government deals lift overhang on pharma group, says BofA

PremiumThe Fly

26d ago

Genentech announces FDA approval of CD20xCD3 bispecific Lunsumio Velo

PremiumThe Fly

26d ago

Roche CEO says drug prices in Switzerland to get higher in future, Reuters says

PremiumThe Fly

27d ago

Trump announces pacts with nine pharma companies to lower drug prices

PremiumThe Fly

29d ago

GSK

PremiumThe FlyGenentech reaches pact with US. to lower costs for state Medicaid programs

29d ago

Drugmakers set to make deals with Trump in exchange for incentives, WaPo reports

The Fly

Drugmakers set to make deals with Trump in exchange for incentives, WaPo reports

29d ago

Top drugmakers to enter agreements with U.S. to cut drug prices, Reuters says

The Fly

Top drugmakers to enter agreements with U.S. to cut drug prices, Reuters says

29d ago